Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation Proctitis

Randomized Trial of Argon Plasma Coagulation Versus Argon Plasma Coagulation and Hemospray in the Therapy of Radiation Proctitis

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02233933

Enrollment

Registered

2014-09-09

Start date

2014-09-30

Completion date

2015-12-31

Last updated

2014-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Bleeding

Keywords

radiation proctitis, bleeding, therapy

Brief summary

Randomized trial of Argon Plasma Coagulation compared with Argon Plasma Coagulation and Hemospray in the therapy of bleeding from Radiation Proctitis

Detailed description

20 patients with Radiation Proctitis will be randomized to receive either Argon Plasma Coagulation therapy alone or therapy with APC followed by Hemospray administration ;the treatment in each arm is administered during a sigmoidoscopic examination

Interventions

OTHERHemospray

hemospray is used after argon coagulation to stop bleeding

Study design

Allocation

RANDOMIZED

Intervention model

FACTORIAL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* bleeding from radiation proctitis

Exclusion criteria

* pregnancy bleeding diathesis

Design outcomes

Primary

Measure	Time frame	Description
cessation of rectal bleeding	12 months	treatment of one group of patients with Radiation Proctitis with Argon Plasma Coagulator ( APC) and a second group will be treated with APC and Hemospray

Secondary

Measure	Time frame
number of treatments required to achieve cessation of rectal bleeding	12 months

Countries

Canada

Contacts

Primary ContactAlan A Weiss, MD

aweiss@bccancer.bc.ca7789979332

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026